NCT07002294 The Effect of SPecialty cAre on Recovery From Cardiac Arrest Trial (the SPARC Trial)
| NCT ID | NCT07002294 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Pittsburgh |
| Condition | Cardiac Arrest (CA) |
| Study Type | INTERVENTIONAL |
| Enrollment | 1,618 participants |
| Start Date | 2026-05-11 |
| Primary Completion | 2031-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 1,618 participants in total. It began in 2026-05-11 with a primary completion date of 2031-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This randomized clinical trial will determine if adult participants who are in the emergency department after being resuscitated from a cardiac arrest outside of the hospital benefit from care delivered at specialized centers. The main question that it will answer is whether transferring participants to a hospital with a specialized cardiac arrest service improves recovery of function after 90 days. Participants will receive all usual medical care, but some participants will be offered transfer to a regional cardiac arrest center and others will be offered care at the closest appropriate hospital. Investigators will interview participants after 90 days to assess their recovery.
Eligibility Criteria
Inclusion Criteria: * Out-of-hospital cardiac arrest * Resuscitated from cardiac arrest with palpable pulse in the emergency department * Treated at one of participating hospital emergency departments * Age ≥18 years Exclusion Criteria: * Known prior advanced directives or decision to limit critical care * Known pre-arrest dependent functional status (e.g., living in a skilled nursing facility, hospice or bedbound) * Arrest in the emergency department \>4 hours after arrival * Traumatic etiology of arrest * Known to have opted-out from the SPARC trial
Contact & Investigator
Jonathan Elmer, MD, MS
PRINCIPAL INVESTIGATOR
University of Pittsburgh
Frequently Asked Questions
Who can join the NCT07002294 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cardiac Arrest (CA). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07002294 currently recruiting?
Yes, NCT07002294 is actively recruiting participants. Contact the research team at difioresm@upmc.edu for enrollment information.
Where is the NCT07002294 trial being conducted?
This trial is being conducted at Pittsburgh, United States.
Who is sponsoring the NCT07002294 clinical trial?
NCT07002294 is sponsored by University of Pittsburgh. The principal investigator is Jonathan Elmer, MD, MS at University of Pittsburgh. The trial plans to enroll 1,618 participants.